Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065277
Company: CHARTWELL MOLECULAR

Products on ANDA 065277

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	EQ 20MG BASE	TABLET;ORAL	Prescription	AB	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 065277

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/10/2005	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/13/2007	SUPPL-3	Labeling		Label is not available on this site.

Therapeutic Equivalents for ANDA 065277

DOXYCYCLINE HYCLATE

TABLET;ORAL; EQ 20MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	210537	ALEMBIC
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	065277	CHARTWELL MOLECULAR
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	065182	EPIC PHARMA LLC
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	065287	LARKEN LABS
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	EQ 20MG BASE	TABLET;ORAL	Prescription	No	AB	065134	SUN PHARM INDUSTRIES